Mechanisms of Nitrosamine Bioactivation and Carcinogenesis

  • Chung S. Yang
  • Theresa J. Smith
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 387)


It was discovered in the mid-1950s by Magee and Barnes that N-nitrosodimethylamine (NDMA) was hepatotoxic. The carcinogenicity of this compound and many other nitrosamines has since been tested by Magee, Druckrey, Preussmann, Schmähl, and others; the results of these pioneer works were summarized in two comprehensive reviews (1,2). The biochemical mechanisms of the carcinogenicity and the structure-activity relationship of the nitrosamines have since been studied by many investigators and the results have been summarized in three recent symposia (3–5). In this chapter, we will discuss the occurrence and carcinogenicity of nitrosamines, the enzyme mechanisms and the organ site of the activation, and the dose-response relationship in carcinogenesis.


Liver Microsome Human Liver Microsome Lung Microsome Diallyl Sulfide Phenethyl Isothiocyanate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



















Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Magee, P. N., and Barnes, J. M. 1967, Carcinogenic nitroso compounds, Adv. Cancer Res.. 10: 163–246.PubMedCrossRefGoogle Scholar
  2. 2.
    Druckrey, H., Preussmann, R., Ivankovic, S., and Schmahl, D. 1967, Organotrope carcinogene Wirkung bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten, S. Krebsforsch.. 69: 103–201.CrossRefGoogle Scholar
  3. 3.
    Loeppky, R. N., and Michejda, C. J. (eds), 1994, The Chemistry and Biochemistry of Nitrosamines and Related N-Nitroso Compounds. ACS Symposium Series 553, Washington, D.C.Google Scholar
  4. 4.
    O’Neill, I. K., Chen, J. C, and Bartsch, H. (eds), 1991, Relevance to Human Cancer of N-Nitroso Compounds. Tobacco Smoke and Mycotoxins. IARC Publications, Lyon, France.Google Scholar
  5. 5.
    Bartsch, H., O’Neill, I. K., and Schulte-Hermann, R. (eds), 1987, The Relevance of N-Nitroso Compounds to Human Cancer: Exposures and Mechanisms. IARC Publications, Lyon, France.Google Scholar
  6. 6.
    National Research Council, N. R., 1981, The Health Effects of Nitrate, Nitrite, and N-Nitroso Compounds. National Academy Press, Washington, D.C.Google Scholar
  7. 7.
    Hecht, S. S. 1994, Metabolic activation and detoxification of tobacco-specific nitrosamines-a model for cancer prevention strategies, Drug Metab. Rev.. 26: 373–390.PubMedCrossRefGoogle Scholar
  8. 8.
    Bartsch, H., 1991, Af-Nitroso compounds and human cancer: Where do we stand? In O’Neill, I. K., Chen, J., and Bartsch, H. (eds.) Relevance to Human Cancer of N-Nitroso Compounds, Tobacco and Mycotoxins. IARC Publications, Lyon, France, 105, pp. 1–10.Google Scholar
  9. 9.
    Yang, C. S., Smith, T., Ishizaki, H., and Hong, J.-Y., 1991, Enzyme mechanisms in the metabolism of nitrosamines. In O’Neill, I. K., Chen, J. C, and Bartsch, H. (eds.) Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke, and Mycotoxins. IARC Publications, Lyon, France, pp. 265–274.Google Scholar
  10. 10.
    Wade, D., Yang, C. S., Metral, C. J., Roman, J. M., Hrabie, J. A., Riggs, C. W., Anjo, T., Keefer, L. K., and Mico, B. A. 1987, Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethyl-amine by rat liver microsomes, Cancer Res.. 47: 3373–3377.PubMedGoogle Scholar
  11. 11.
    Appel, K. E., Ruhl, C. S., and Hildebrandt, A. G., 1985, Oxidative dealkylation and reductive denitrosation of nitrosomethylaniline in vitro, Chem. Biol. Interactions, 53: 69–76.CrossRefGoogle Scholar
  12. 12.
    Ji, C., Mirvish, S. S., Nickols, J., Ishizaki, H., Lee, M. J., and Yang, C. S. 1989, Formation of hydroxy derivatives, aldehydes, and nitrite from N-nitrosomethyl-n-amylamine by rat liver microsomes and by purified cytochrome P-450 IIB1, Cancer Res.. 49: 5299–5304.PubMedGoogle Scholar
  13. 13.
    Yang, C. S., Tu, Y. Y, Koop, D. R., and Coon, M. J. 1985, Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes, Cancer Res.. 45: 1140–1145.PubMedGoogle Scholar
  14. 14.
    Patten, C. J., Ning, S. M., Lu, A. Y H., and Yang, C. S., 1986, Acetone-inducible cytochrome P-450: purification, catalytic activity and interaction with cytochrome b 5,Arch. Biochem. Biophys., 251: 629–638.PubMedCrossRefGoogle Scholar
  15. 15.
    Patten, C, Ishizaki, H., Aoyama, T., Lee, M. J., Ning, S. M., Huang, W, Gonzalez, F. J., and Yang, C. S. 1992, Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cells, Arch. Biochem. Biophys.. 299: 163–171.PubMedCrossRefGoogle Scholar
  16. 16.
    Yoo, J.-S. H., and Yang, C. S., 1985, Enzyme specificity in the metabolic activation of N-nitrosodimethylamine to a mutagen for Chinese hamster V79 cells. Cancer Res., 45: 5569–5574.PubMedGoogle Scholar
  17. 17.
    Yoo, J.-S. H., Ishizaki, H., and Yang, C. S. 1990, Roles of cytochrome P450IIE1 in the dealkylation and denitrosation of N-nitrosodime thy lamine and N-nitrosodiethylamine in rat liver microsomes, Carcinogenesis (Lond). 11: 2239–2243.CrossRefGoogle Scholar
  18. 18.
    Yamazaki, H., Inui, Y, Yun, C.-H., Guengerich, F. P., and Shimada, T. 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes, Carcinogenesis. 13: 1789–1794.PubMedCrossRefGoogle Scholar
  19. 19.
    Lee, M., Ishizaki, H., Brady, J. F., and Yang, C. S. 1989, Substrate specificity and alkyl group selectivity in the metabolism of N-nitrosodialkylamines, Cancer Res.. 49: 1470–1474.PubMedGoogle Scholar
  20. 20.
    Wang, M.-H., Wade, D., Chen, L., White, S., and Yang, C. S. 1995, Probing the active sites of rat and human cytochrome P450 2E1 with alcohols and carboxylic acids, Arch. Biochem. Biophys.. 317: 299–304.PubMedCrossRefGoogle Scholar
  21. 21.
    Mehta, R., Labuc, G. E., and Archer, M. C, 1984, Tissue and species specificity of the microsomal metabolism of nitrosomethylbenzylamine. In Bartsch, H., and O’Neill, I. K. (eds.) N-Nitroso compounds: Occurrence and Biological Effects. IARC Publications, Lyon, France, pp. 473–478.Google Scholar
  22. 22.
    Ludeke, B., Meier, T., and Kleihues, P., 1991, Metabolism of N’-nitrosomethylbenzylamine (NMBzA) in rat esophageal and liver microsomes. In O’Neill, I. K., Chen, J. C., and Bartsch, H. (eds.) Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins. IARC Publications, Lyon, France, pp. 286–293.Google Scholar
  23. 23.
    Lu, S. H., Chui, S. X., Yang, W. X., Hu, X. N., Guo, L. P., and Li, F. M., 1991, Relevance of N-nitrosamines to esophageal cancer in China. In O’Neill, I. K., Chen, J., and Bartsch, H. (eds.) Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins. IARC Scientific, Lyon, France, 105, pp. 11–17.Google Scholar
  24. 24.
    Smith, T. J., Guo, Z.-Y., Thomas, P. E., Chung, F.-L., Morse, M. A., Eklind, K., and Yang, C. S. 1990, Metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in mouse lung microsomes and its inhibition by isothiocyanates, Cancer Res.. 50: 6817–6822.PubMedGoogle Scholar
  25. 25.
    Guo, Z., Smith, T. J., Thomas, P. E., and Yang, C. S. 1991, Metabolic activation of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone as measured by DNA alkylation in vitro and its inhibition by isothiocyanates, Cancer Res.. 51: 4798–4803.PubMedGoogle Scholar
  26. 26.
    Guo, Z., Smith, T. J., Ishizaki, H., and Yang, C. S. 1991, Metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system, Carcinogenesis (Lond.). 12: 2277–2282.CrossRefGoogle Scholar
  27. 27.
    Smith, T. J., Guo, Z., Gonzalez, F. J., Guengerich, F. P., Stoner, G. D., and Yang, C. S. 1992, Metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) in human lung and liver microsomes and cytochrome P-450 expressed in hepatoma cells, Cancer Res.. 52: 1757–1763.PubMedGoogle Scholar
  28. 28.
    Smith, T. J., Guo, Z.-Y, Hong, J.-Y, Ning, S. M., Thomas, P. E., and Yang, C. S. 1992, Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosmino)-l-(3-pyridyl)-l-butanone (NNK) by rat lung and nasal mucosa microsomes, Carcinogenesis (Lond.). 13: 1409–1414.CrossRefGoogle Scholar
  29. 29.
    Guo, Z., Smith, T. J., Thomas, P. E., and Yang, C. S. 1992, Metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) by inducible and constitutive cytochrome P450 enzymes in rats, Arch. Biochem. Biophys.. 298: 279–286.PubMedCrossRefGoogle Scholar
  30. 30.
    Hong, J.-Y, Smith, T., Lee, M.-J., Li, W., Ma, B.-L., Ning, S.-M., Brady, J. F., Thomas, P. E., and Yang, C. S. 1991, Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide, Cancer Res.. 51: 1509–1514.PubMedGoogle Scholar
  31. 31.
    Hong, J.-Y, Ding, X., Smith, T. J., Coon, M. J., and Yang, C. S. 1992, Metabolism of 4-(methylni-trosamino)-l-(3-pyridyl)-l-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsmes and cytochrome P450s NMa and NMb, Carcinogenesis (Lond.). 13: 2141–2144.CrossRefGoogle Scholar
  32. 32.
    Penman, B. W., Reece, J., Smith, T., Yang, C. S., Gelboin, H. V., Gonzalez, F. J., and Crespi, C. L. 1992, Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6, Pharmacogenetics. 3: 28–39.CrossRefGoogle Scholar
  33. 33.
    Murphy, S. E., Heiblum, R., and Trushin, N. 1990, Comparative metabolism of-nitrosonornicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone by cultured F344 rat oral tissue and esophagus, Cancer Res.. 50: 4685–4691.PubMedGoogle Scholar
  34. 34.
    Murphy, S. E., and Heiblum, R. 1990, Effect of nicotine and tobacco-specific nitrosamines on the metabolism of W-nitrosonornicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone by rat oral tissue, Carcinogenesis. 11: 1663–1666.PubMedCrossRefGoogle Scholar
  35. 35.
    McCoy, G. D., Chen, C.-H. B., and Hecht, S. S. 1981, Influence of mixed-function oxidase inducers on the in vitro metabolism of 7V-nitrosonornicotine by rat and hamster liver microsomes, Drug Metab. Disp.. 9: 168–169.Google Scholar
  36. 36.
    Chen, C.-H. B., Fung, P. T., and Hecht, S. S. 1979, Assay for microsomal αhydroxylation of N′-nitrosonornicotine and determination of the deuterium isotope effect for a-hydroxylation, Cancer Res.. 39: 5057–5062.PubMedGoogle Scholar
  37. 37.
    Smith, T. J., Guo, Z., Li, C, Ning, S. M., Thomas, P. E., and Yang, C. S. 1993, Mechanisms of inhibition of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) bioactivation in mouse by dietary phenethyl isothiocyanate, Cancer Res.. 53: 3276–3282.PubMedGoogle Scholar
  38. 38.
    Hodgson, R. M., Schweinsberg, F., Wiessler, M., and Kleihues, P. 1982, Mechanism of esophageal tumor induction in rats by N’-nitrosomethylbenzylamine and its ring-methylated analog N-nitrosomethyl(4-methylbenzyl)amine, Cancer Res.. 42: 2836–2840.PubMedGoogle Scholar
  39. 39.
    Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. S. 1991, A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P450 2D6, Carcinogenesis. 12: 1197–1201.PubMedCrossRefGoogle Scholar
  40. 40.
    Peto, R., Gray, R., Brantom, P., and Grasso, P. 1991, Effects on 4080 rat chronic ingestion of 7V-nitrosodiethylamine or N-nitrosodimethylamine: A detailed dose-response study, Cancer Res.. 51: 6415–6451.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Chung S. Yang
    • 1
  • Theresa J. Smith
    • 1
  1. 1.Laboratory for Cancer Research College of PharmacyRutgers UniversityPiscatawayUSA

Personalised recommendations